Update of minimally invasive surfactant therapy.

In conclusion, MIST is gentle, safe, feasible, and effective in preterm infants, and is widely used for surfactant administration with noninvasive respiratory support by neonatologists. However, further studies are needed to resolve uncertainties in the MIST method, including infant selection, optimal surfactant dosage and administration method, and need for sedation. PMID: 29042870 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/29042870?dopt=Abstract

Source: Korean Journal of Pediatrics - October 20, 2017 Category: Pediatrics Tags: Korean J Pediatr Source Type: research